256 related articles for article (PubMed ID: 16150649)
21. Targeted delivery of in situ PCR-amplified Sleeping Beauty transposon genes to cancer cells with lipid-based nanoparticle-like protocells.
Ma K; Fu D; Yu D; Cui C; Wang L; Guo Z; Mao C
Biomaterials; 2017 Mar; 121():55-63. PubMed ID: 28081459
[TBL] [Abstract][Full Text] [Related]
22. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy.
Joki T; Machluf M; Atala A; Zhu J; Seyfried NT; Dunn IF; Abe T; Carroll RS; Black PM
Nat Biotechnol; 2001 Jan; 19(1):35-9. PubMed ID: 11135549
[TBL] [Abstract][Full Text] [Related]
23. Sleeping Beauty-baculovirus hybrid vectors for long-term gene expression in the eye.
Turunen TA; Laakkonen JP; Alasaarela L; Airenne KJ; Ylä-Herttuala S
J Gene Med; 2014; 16(1-2):40-53. PubMed ID: 24464652
[TBL] [Abstract][Full Text] [Related]
24. Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect.
Szentirmai O; Baker CH; Lin N; Szucs S; Takahashi M; Kiryu S; Kung AL; Mulligan RC; Carter BS
Neurosurgery; 2006 Feb; 58(2):365-72; discussion 365-72. PubMed ID: 16462491
[TBL] [Abstract][Full Text] [Related]
25. Combination therapy with antiangiogenic treatment and photodynamic therapy for the nude mouse bearing U87 glioblastoma.
Jiang F; Zhang X; Kalkanis SN; Zhang Z; Yang H; Katakowski M; Hong X; Zheng X; Zhu Z; Chopp M
Photochem Photobiol; 2008; 84(1):128-37. PubMed ID: 18173712
[TBL] [Abstract][Full Text] [Related]
26. Counterselection and co-delivery of transposon and transposase functions for Sleeping Beauty-mediated transposition in cultured mammalian cells.
Converse AD; Belur LR; Gori JL; Liu G; Amaya F; Aguilar-Cordova E; Hackett PB; McIvor RS
Biosci Rep; 2004 Dec; 24(6):577-94. PubMed ID: 16158196
[TBL] [Abstract][Full Text] [Related]
27. Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice.
Chen QR; Kumar D; Stass SA; Mixson AJ
Cancer Res; 1999 Jul; 59(14):3308-12. PubMed ID: 10416583
[TBL] [Abstract][Full Text] [Related]
28. Hyperactive transposase mutants of the Sleeping Beauty transposon.
Baus J; Liu L; Heggestad AD; Sanz S; Fletcher BS
Mol Ther; 2005 Dec; 12(6):1148-56. PubMed ID: 16150650
[TBL] [Abstract][Full Text] [Related]
29. Development of lentiviral vectors for antiangiogenic gene delivery.
Shichinohe T; Bochner BH; Mizutani K; Nishida M; Hegerich-Gilliam S; Naldini L; Kasahara N
Cancer Gene Ther; 2001 Nov; 8(11):879-89. PubMed ID: 11773978
[TBL] [Abstract][Full Text] [Related]
30. Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system.
Huang X; Wilber AC; Bao L; Tuong D; Tolar J; Orchard PJ; Levine BL; June CH; McIvor RS; Blazar BR; Zhou X
Blood; 2006 Jan; 107(2):483-91. PubMed ID: 16189271
[TBL] [Abstract][Full Text] [Related]
31. Bevacizumab with angiostatin-armed oHSV increases antiangiogenesis and decreases bevacizumab-induced invasion in U87 glioma.
Zhang W; Fulci G; Buhrman JS; Stemmer-Rachamimov AO; Chen JW; Wojtkiewicz GR; Weissleder R; Rabkin SD; Martuza RL
Mol Ther; 2012 Jan; 20(1):37-45. PubMed ID: 21915104
[TBL] [Abstract][Full Text] [Related]
32. Effects of sustained antiangiogenic therapy in multistage prostate cancer in TRAMP model.
Isayeva T; Chanda D; Kallman L; Eltoum IE; Ponnazhagan S
Cancer Res; 2007 Jun; 67(12):5789-97. PubMed ID: 17575146
[TBL] [Abstract][Full Text] [Related]
33. Antitumoral and antimetastatic effect of antiangiogenic plasmids in B16 melanoma: Higher efficiency of the recombinant disintegrin domain of ADAM 15.
Daugimont L; Vandermeulen G; Defresne F; Bouzin C; Mir LM; Bouquet C; Feron O; Préat V
Eur J Pharm Biopharm; 2011 Aug; 78(3):314-9. PubMed ID: 21316447
[TBL] [Abstract][Full Text] [Related]
34. Cytoplasmic injection of murine zygotes with Sleeping Beauty transposon plasmids and minicircles results in the efficient generation of germline transgenic mice.
Garrels W; Talluri TR; Ziegler M; Most I; Forcato DO; Schmeer M; Schleef M; Ivics Z; Kues WA
Biotechnol J; 2016 Jan; 11(1):178-84. PubMed ID: 26470758
[TBL] [Abstract][Full Text] [Related]
35. Efficient and stable transgene expression in human embryonic stem cells using transposon-mediated gene transfer.
Wilber A; Linehan JL; Tian X; Woll PS; Morris JK; Belur LR; McIvor RS; Kaufman DS
Stem Cells; 2007 Nov; 25(11):2919-27. PubMed ID: 17673526
[TBL] [Abstract][Full Text] [Related]
36. Combinatorial anti-angiogenic gene therapy in a human malignant mesothelioma model.
Kubo S; Takagi-Kimura M; Kasahara N
Oncol Rep; 2015 Aug; 34(2):633-8. PubMed ID: 26082103
[TBL] [Abstract][Full Text] [Related]
37. Liver-directed gene therapy using the sleeping beauty transposon system.
Belur LR; McIvor RS; Wilber A
Methods Mol Biol; 2008; 434():267-76. PubMed ID: 18470650
[TBL] [Abstract][Full Text] [Related]
38. Gene transfer into genomes of human cells by the sleeping beauty transposon system.
Geurts AM; Yang Y; Clark KJ; Liu G; Cui Z; Dupuy AJ; Bell JB; Largaespada DA; Hackett PB
Mol Ther; 2003 Jul; 8(1):108-17. PubMed ID: 12842434
[TBL] [Abstract][Full Text] [Related]
39. Anti-tumor efficacy of human angiostatin using liver-mediated adeno-associated virus gene therapy.
Lalani AS; Chang B; Lin J; Case SS; Luan B; Wu-Prior WW; VanRoey M; Jooss K
Mol Ther; 2004 Jan; 9(1):56-66. PubMed ID: 14741778
[TBL] [Abstract][Full Text] [Related]
40. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin.
Zhang X; Xu J; Lawler J; Terwilliger E; Parangi S
Clin Cancer Res; 2007 Jul; 13(13):3968-76. PubMed ID: 17606731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
